Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris

Recruiting

Phase 2

DeucravacitinibDeucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris

Sponsor:

Mayo Clinic

Code:

NCT06444399

Conditions

Pityriasis Rubra Pilaris

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Deucravacitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-19. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2025-08-08.